AS Watson, the conglomerate behind popular health and beauty retailer Superdrug, is reportedly weighing up a substantial dual listing that would see its shares traded in both London and Hong Kong. This strategic move could value the company at an estimated £24 billion ($30 billion) and aims to raise approximately £1.6 billion ($2 billion) in capital. The potential float is anticipated to take place before the end of 2026, marking a significant development for both the company and the London Stock Exchange.
For the UK's financial landscape, a listing of this magnitude would be a considerable boost. In recent times, there have been concerns over companies choosing other global financial centres over London for their initial public offerings (IPOs). The arrival of a major player like AS Watson, with its strong brand recognition through Superdrug, would signal renewed confidence in the City of London's appeal as a destination for large-scale public listings, potentially encouraging other international firms to follow suit.
AS Watson's portfolio extends far beyond Superdrug, encompassing a vast network of health and beauty stores, supermarkets, and electronics retailers across 28 markets worldwide. Its owner, CK Hutchison Holdings, is a Hong Kong-based multinational conglomerate with diverse interests. This proposed dual listing strategy allows AS Watson to tap into a wider pool of international investors, balancing the established financial markets of Asia with the deep capital markets of Europe.
Should the listing proceed, it would provide an opportunity for UK investors, including those with pension funds and ISAs, to potentially invest in a company with a strong consumer presence on British high streets. The capital raised could also be used by AS Watson for further expansion, acquisitions, or to strengthen its balance sheet, which could indirectly impact the wider retail ecosystem and supply chains within the UK.
The current economic climate, characterised by fluctuating interest rates and ongoing inflationary pressures, makes the timing of such a listing particularly notable. The Bank of England's recent monetary policy decisions, aimed at bringing inflation back to its 2% target, continue to influence investor sentiment. A successful listing by AS Watson could be seen as a positive indicator of market resilience and appetite for investment in established consumer-facing businesses, even amidst broader economic uncertainties.
While this development primarily concerns the investment community, the presence of Superdrug on UK high streets means the brand is highly familiar to millions of British consumers. Any strategic shifts or financial bolstering of its parent company could, in the long term, influence Superdrug's operational strategies, pricing, and expansion plans, though direct impacts on consumers are not immediately apparent.
Source: City A.M.